Search Filters
Specialties
Genetics
Specialties
Regenerative Medicine
Clear All
Search
Specialties
Genetics
Specialties
Regenerative Medicine
24 results found in 4ms
ChondroFiller injection vs PRP for cartilage repair
avatar
Miss Sophie Harris
10/6/2026
ChondroFiller injection vs PRP for cartilage repair
ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.
Finding a ChondroFiller specialist in the UK
avatar
Miss Sophie Harris
7/6/2026
Finding a ChondroFiller specialist in the UK
ChondroFillerinjectionfor focal cartilage defects requires real-time ultrasound guidance during placement. Most UK clinics lack this capability, so trained specialists concentrate in London.ChondroFiller injection for focal cartilage defects requires real-time ultrasound guidance during placement. Most UK clinics lack this capability, so trained specialists concentrate in London.
ChondroFiller durability vs Arthrosamid and hyaluronic acid
avatar
Miss Sophie Harris
6/6/2026
ChondroFiller durability vs Arthrosamid and hyaluronic acid
ChondroFiller's collagen scaffold breaks down in six to twenty-four months, but the clinical benefit lasts one to five years or longer because the material recruits the patient's own progenitor cells to support cartilage repair, not to act as permanent filling.ChondroFiller's collagen scaffold breaks down in six to twenty-four months, but the clinical benefit lasts one to five years or longer because the material recruits the patient's own progenitor cells to support cartilage repair, not to act as permanent filling.
ChondroFiller success rates in practice
avatar
Miss Sophie Harris
5/6/2026
ChondroFiller success rates in practice
ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.
24 results found in 4ms